Early research (Phase 1)Study completedNCT00095160
What this trial is testing
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42